The Increasing number of Allergic Patients due to Changing Lifestyles, Food Habits, and the Environment is Expected to Propel the Growth of The Global Fexofenadine HCL Market.

The global fexofenadine hydrochloride (HCL) market is anticipated to grow at a considerable CAGR during the forecast years. The antihistamine fexofenadine HCL is used to treat seasonal allergic rhinitis and urticaria. Seasonal allergic rhinitis is an allergic reaction that occurs when the seasons or weather change at least once a year. A runny or stuffy nose, itchy or watery eyes, sneezing, and other symptoms are experienced by the patient. The demand for fexofenadine HCL medications to treat seasonal allergic rhinitis is anticipated to rise as the number of patients suffering from the condition grows. Fexofenadine HCL is an H1 blocker that works by preventing histamines from binding to the H1 receptor. 

Browse the full report description “Global Fexofenadine Hydrochloride (HCL) Market Size, Share & Trend Analysis Report by Application (Seasonal Allergic Rhinitis, and Urticaria), By Dosage Form (Tablets, and Oral Suspension), Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/fexofenadine-hydrochloride-market 

In addition, fexofenadine HCL is also used for the treatment of urticaria patients. Urticaria (Hives) is an allergy, that causes rashes on the skin with intense itchiness. The changing food habits of people and weather conditions are the reason for the increasing number of patients suffering urticaria has increased the demand for antihistamines including fexofenadine HCL. Fexofenadine HCL comes in two forms including tablets for the treatment of adults and children, and oral suspension for babies and children of age below 12. For instance, in 2021, a report published by Biosciences Biotechnology Research Asia (BBRA) has concluded that fexofenadine HCL can be used as the first-line therapy for symptoms of allergic rhinitis and urticaria as it offers various benefits such as more convenient, cost-effective, and a large margin of safety. Furthermore, fexofenadine also comes in generic form with the brand name 'Allegra’ which is expected to result in increased demand for fexofenadine HCL propelling the growth of the global fexofenadine HCL market.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Application
• By Dosage Form

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- AstraZeneca group Co., Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Novartis International AG, Methpharm, Inc., and Others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Fexofenadine HCL Market Report Segment

By Application

• Seasonal Allergic Rhinitis
• Urticaria

By Dosage Form

• Tablets
• Oral Suspension

Global Fexofenadine HCL Market Report Segment by Region

North America

• The US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/fexofenadine-hydrochloride-market